GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioptik Technology Inc (ROCO:4161) » Definitions » Debt-to-Asset

Bioptik Technology (ROCO:4161) Debt-to-Asset : 0.34 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bioptik Technology Debt-to-Asset?

Bioptik Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$372.8 Mil. Bioptik Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$138.6 Mil. Bioptik Technology's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was NT$1,496.4 Mil. Bioptik Technology's debt to asset for the quarter that ended in Sep. 2024 was 0.34.


Bioptik Technology Debt-to-Asset Historical Data

The historical data trend for Bioptik Technology's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioptik Technology Debt-to-Asset Chart

Bioptik Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.44 0.45 0.44 0.35

Bioptik Technology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.35 0.36 0.34 0.34

Competitive Comparison of Bioptik Technology's Debt-to-Asset

For the Medical Devices subindustry, Bioptik Technology's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioptik Technology's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bioptik Technology's Debt-to-Asset falls into.



Bioptik Technology Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bioptik Technology's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(368.032 + 155.21) / 1497.706
=0.35

Bioptik Technology's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(372.773 + 138.598) / 1496.394
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioptik Technology  (ROCO:4161) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Bioptik Technology Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bioptik Technology's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioptik Technology Business Description

Traded in Other Exchanges
N/A
Address
No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.

Bioptik Technology Headlines

No Headlines